evolcSign inStart free
Menu

Antigenika

Developing an oral, broad-spectrum snakebite treatment for people in regions with limited access to hospital antivenom

Stokenchurch, United KingdomFounded 2024antigenika.comWebsite technologies

+ Add to sales board

Highlights

  • Young companyFounded 2024
  • New on EvolcAdded 2026-11-09

About Antigenika

Antigenika is developing an oral small-molecule therapy intended to treat snakebite envenoming across multiple snake species. The treatment is designed to be heat-stable and usable outside hospitals.

The company is focused on high-burden markets, with an India-first launch plan and phased expansion into other regions. It is preparing Phase I safety studies in healthy volunteers, followed by planned Phase II trials in snakebite patients.

Antigenika originated from venom research at the University of Reading. ANTIGENIKA LTD was founded in 2024 and is registered in Stokenchurch, United Kingdom.

Product: An oral, heat-stable small-molecule therapy in development for broad-spectrum snakebite treatment.

Jobs at Antigenika

No open positions listed right now.

Leadership

More biotech & pharma companies

  • Antiverse

    AI-guided antibody discovery and laboratory validation for pharmaceutical and biotech partners targeting GPCRs
    Cardiff, United KingdomBiotech & pharmaFounded 2017
    New on Evolc

  • Apconix

    Nonclinical drug safety consultancy and ion channel screening lab for pharma and biotech drug developers
    Alderley Edge, United KingdomBiotech & pharmaFounded 2014
    New on Evolc

  • Apis Assay Technologies

    Molecular diagnostic assay kits and contract IVD development for diagnostics, biotech and pharma teams
    Manchester, United KingdomBiotech & pharmaFounded 20181 open job
    New on Evolc

  • Apollo Scientific

    Supplies research chemicals, life-science reagents and synthesis services to laboratories, researchers and manufacturers
    Manchester, United KingdomBiotech & pharmaFounded 1993
    New on Evolc

  • Apollo Therapeutics

    Portfolio biopharmaceutical company developing new medicines from university biomedical research and in-licensed clinical programs
    Cambridge, United KingdomBiotech & pharmaFounded 2021
    New on Evolc

  • Apterna

    Preclinical biotech developing liver-directed RNA therapies to restore liver function for patients with liver cancer
    London, United KingdomBiotech & pharmaFounded 2011
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Content delivery

  • CloudflareHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • Next.jsHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • ReactMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.